Lagerstandorte

New Jersey, USA
Czech Republic, EU
Mumbai, India

* Vorbehaltlich Verfügbarkeit

Dokumentation

MSDS herunterladen

Beispiel-COA herunterladen

Enthält: HPLC, MASS/LC-MS, 1H-NMR, FT-IR, Gehalt, Structure Elucidation Report (SER) sowie zusätzliche analytische Daten je nach Produkt.

817204-33-4Sofosbuvir Impurity 115

● Auf Lager

Katalog-Nr.::	VE0022927
CAS-Nr.::	817204-33-4
Summenformel::	C10H14FN3O4
Molare Masse::	259.24 g/mol

Angebot anfordern

Zur RFQ-Liste hinzufügen

Zusätzliche Informationen zu CAS 817204-33-4

Parent drug

Sofosbuvir

IUPAC-Name

4-amino-1-((2R, 3R, 4R, 5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)-3-methyltetrahydrofuran-2-yl)pyrimidin-2(1H)-one

Pharmakopöe-Synonyme

N/A

Other Synonyms

2′-deoxy-2′-fluoro-2′-C-methylcytidine

SMILES

O=C1N([C@@H]2O[C@H](CO)[C@@H](O)[C@@]2(C)F)C=CC(N)=N1

InChI

InChI=1S/C10H14FN3O4/c1-10(11)7(16)5(4-15)18-8(10)14-3-2-6(12)13-9(14)17/h2-3, 5, 7-8, 15-16H, 4H2, 1H3, (H2, 12, 13, 17)/t5-, 7-, 8-, 10-/m1/s1

Beschreibung

Sofosbuvir Impurity 115 is a meticulously characterized reference material that complies with rigorous regulatory requirements | including those defined by USP | EMA | JP | and BP. This product plays a crucial role in Abbreviated New Drug Applications (ANDA) | New Drug Applications (NDA) | and the commercial manufacturing of Sofosbuvir. It is further supported by a detailed Structure Elucidation Report (SER) | ensuring high accuracy and reliability across a broad range of analytical applications.